Recent advances in cancer research have led to the development of several promising INDs, including:
- CAR-T Cell Therapy: A form of immunotherapy that modifies a patient's own T cells to target and kill cancer cells. - PARP Inhibitors: Drugs that target specific weaknesses in cancer cells' DNA repair mechanisms. - Checkpoint Inhibitors: Immunotherapies that help the body's immune system recognize and attack cancer cells. - Targeted Therapies: Drugs designed to target specific genetic mutations or proteins that drive cancer growth.
